SEC Form 4 · accession 0000899243-15-008210
Marker Therapeutics, Inc. · MRKR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glynn Wilson
Director
Period of report
Nov 12, 2015
Accepted (ET)
Nov 16, 2015 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001094038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 12, 2015 | A | 315,000 | $0.605 | A | 960,457 | D | |
| Common StockF2 | Nov 12, 2015 | F | 86,782 | $0.605 | A | 873,675 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $0.605 | Nov 12, 2015 | A | 2,000,000 | A | Nov 12, 2015 | Nov 12, 2025 | Common Stock | 2,000,000 | 2,038,000 | D |
Explanation of responses
- F1Represents shares of fully vested restricted stock issued under the Company's 2014 Omnibus Stock Ownership Plan to Dr. Wilson in connection with his employment and the execution of his employment agreement.
- F2Represents withholding of shares of common stock to satisfy tax withholding obligations in connection with the issuance of the restricted stock award.
- F3Represents options awarded under the Company's 2014 Omnibus Stock Ownership Plan in connection with the execution of Dr. Wilson's employment agreement with the Company. One million of such shares vest immediately, the remaining 1,000,000 shares vest in 23 equal monthly installments of 41,666 shares each on the last day of each of the 23 months following the grant date, and the remaining 41,682 options vest on the last day of the 24th month. The option exercise price is the closing price on the date of the grant, On November 12, 2015.